Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 48:379-384, October 2007
doi: 10.1176/appi.psy.48.5.379
© 2007 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Joffe, R. T.
* Articles by Stagnaro-Green, A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Joffe, R. T.
* Articles by Stagnaro-Green, A.
Related Collections
* Syndromes Secondary to General Medical Disorders

Review

Treatment of Clinical Hypothyroidism With Thyroxine and Triiodothyronine: A Literature Review and Metaanalysis

Russell T. Joffe, M.D., Michael Brimacombe, Ph.D., Anthony J. Levitt, M.D., and Alex Stagnaro-Green, M.D.

Received February 27, 2006; revised March 7, 2007; accepted May 10, 2007. From the Dept. of Psychiatry, Dept. of Preventive Medicine, and the Div. of Endocrinology and Dept. of Medicine, UMDNJ–New Jersey Medical School, Newark, NJ; the Dept. of Psychiatry, Sunnybrook Hospital, and the Univ. of Toronto, Toronto, Ontario, Canada. Send correspondence and reprint requests to Russell T. Joffe, M.D., New Jersey Medical School, 111 Dunnell Rd., Maplewood, NJ 07040. e-mail: joffe{at}umdnj.edu
© 2007 The Academy of Psychosomatic Medicine

Thyroxine is the standard replacement therapy for patients with clinical hypothyroidism. However, there has been recent interest in examining the potential advantages of combined thyroxine and triiodothyronine treatment for the treatment of hypothyroidism. The authors review the nine studies to-date and conclude that the variability and limitations in study design make definitive and clinically useful recommendations difficult. They therefore conducted a metaanalysis of the nine controlled studies examining the impact of combined thyroxine-plus-triiodothyronine versus thyroxine alone, with measures of psychiatric symptoms as the primary outcome. Their analysis reveals no significant difference in treatment effect on psychiatric symptoms in the nine controlled studies to date.




This article has been cited by other articles:


Home page
JAMAHome page
D. S. Cooper
Thyroxine Monotherapy After Thyroidectomy: Coming Full Circle
JAMA, February 20, 2008; 299(7): 817 - 819.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org